Loading…
Viromed Medical AG signed a distribution partnership with TriPart TITAN GmbH & Co. KG to market its ViroCAP and PulmoPlas cold plasma medical devices in Turkey. The sales launch is planned for Q1 2026, with initial orders of 5,000 ViroCAP and 750 PulmoPlas units.
Viromed Medical AG and UMECO Group signed an exclusive five-year distribution agreement for cold plasma medical devices ViroCAP and PulmoPlas in ten Asian countries. The deal is valued at EUR 152.5 million, including a USD 5 million license fee and purchase commitments through 2028.